Third Quarter 2022 Results

Bayer AG Media Conference Call

Bayer with Continued Strong Performance

  • Group sales increase by 5.7 percent (Fx & portfolio adj.) to 11.281 billion euros
  • EBITDA before special items rises by 17.3 percent to 2.451 billion euros
  • Crop Science achieves strong sales gains – sales also up at Pharmaceuticals and Consumer Health
  • All divisions report significant increase in earnings
  • Core earnings per share climb by 7.6 percent to 1.13 euros
  • Net income at 546 million euros
  • Free cash flow at 1.738 billion euros
  • Major progress in Pharmaceuticals pipeline
  • Full-year Group outlook confirmed


Stay tuned and follow us: